1. Home
  2. NTCT vs AAPG Comparison

NTCT vs AAPG Comparison

Compare NTCT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$42.92

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$19.08

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
AAPG
Founded
1984
2009
Country
United States
China
Employees
N/A
767
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
NTCT
AAPG
Price
$42.92
$19.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$31.00
$48.40
AVG Volume (30 Days)
528.6K
7.3K
Earning Date
05-07-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
125.39
N/A
EPS
1.30
N/A
Revenue
$891,820,000.00
N/A
Revenue This Year
$6.02
$290.34
Revenue Next Year
$2.55
N/A
P/E Ratio
$31.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.40
$18.56
52 Week High
$42.37
$48.45

Technical Indicators

Market Signals
Indicator
NTCT
AAPG
Relative Strength Index (RSI) 72.45 38.26
Support Level $26.16 $18.56
Resistance Level N/A $27.98
Average True Range (ATR) 1.32 0.90
MACD 0.15 0.07
Stochastic Oscillator 99.32 18.16

Price Performance

Historical Comparison
NTCT
AAPG

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: